

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of synapse structural plasticity (GO:0051823) | 6.27466473 |
| 2 | prepulse inhibition (GO:0060134) | 5.89370341 |
| 3 | synaptic transmission, dopaminergic (GO:0001963) | 5.86155410 |
| 4 | sodium ion export (GO:0071436) | 5.50556198 |
| 5 | adenosine receptor signaling pathway (GO:0001973) | 5.41276484 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.37296179 |
| 7 | striatum development (GO:0021756) | 5.28671289 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.27677731 |
| 9 | synaptic vesicle maturation (GO:0016188) | 5.24701097 |
| 10 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.04743948 |
| 11 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.89774667 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.87680648 |
| 13 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.76575144 |
| 14 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.69689776 |
| 15 | cerebellar granule cell differentiation (GO:0021707) | 4.69285340 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.64793030 |
| 17 | auditory behavior (GO:0031223) | 4.63074461 |
| 18 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.57117719 |
| 19 | vocalization behavior (GO:0071625) | 4.56765024 |
| 20 | response to amphetamine (GO:0001975) | 4.55365143 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.51220145 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.50812953 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.48338459 |
| 24 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.47306083 |
| 25 | positive regulation of synapse maturation (GO:0090129) | 4.45986128 |
| 26 | dopamine receptor signaling pathway (GO:0007212) | 4.35342486 |
| 27 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.35019104 |
| 28 | neuromuscular process controlling balance (GO:0050885) | 4.33859580 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.32006500 |
| 30 | L-amino acid import (GO:0043092) | 4.29457174 |
| 31 | cAMP catabolic process (GO:0006198) | 4.23223324 |
| 32 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.21513988 |
| 33 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.18032674 |
| 34 | positive regulation of neurotransmitter transport (GO:0051590) | 4.13956910 |
| 35 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.13092757 |
| 36 | behavioral response to cocaine (GO:0048148) | 4.12654999 |
| 37 | response to auditory stimulus (GO:0010996) | 4.07414029 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.05083455 |
| 39 | synaptic vesicle exocytosis (GO:0016079) | 4.03025009 |
| 40 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.00070077 |
| 41 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.00070077 |
| 42 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.96539044 |
| 43 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.95035889 |
| 44 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.95035889 |
| 45 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.91249380 |
| 46 | cell communication by electrical coupling (GO:0010644) | 3.88885723 |
| 47 | neurotransmitter secretion (GO:0007269) | 3.85028424 |
| 48 | potassium ion homeostasis (GO:0055075) | 3.82172859 |
| 49 | amino acid import (GO:0043090) | 3.81909873 |
| 50 | potassium ion import (GO:0010107) | 3.81308612 |
| 51 | neuron-neuron synaptic transmission (GO:0007270) | 3.80034862 |
| 52 | exploration behavior (GO:0035640) | 3.79395362 |
| 53 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.79134078 |
| 54 | neuronal ion channel clustering (GO:0045161) | 3.77843023 |
| 55 | activation of protein kinase A activity (GO:0034199) | 3.74835449 |
| 56 | regulation of female receptivity (GO:0045924) | 3.72280759 |
| 57 | dendritic spine morphogenesis (GO:0060997) | 3.71660448 |
| 58 | regulation of synapse maturation (GO:0090128) | 3.71355805 |
| 59 | cyclic nucleotide catabolic process (GO:0009214) | 3.71036910 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.69068376 |
| 61 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.68475037 |
| 62 | neurotransmitter transport (GO:0006836) | 3.67827114 |
| 63 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.67759755 |
| 64 | regulation of glutamate secretion (GO:0014048) | 3.67269892 |
| 65 | negative regulation of dendrite development (GO:2000171) | 3.66807088 |
| 66 | transmission of nerve impulse (GO:0019226) | 3.65741165 |
| 67 | regulation of neurotransmitter uptake (GO:0051580) | 3.65434021 |
| 68 | peristalsis (GO:0030432) | 3.62731789 |
| 69 | long-term memory (GO:0007616) | 3.61728886 |
| 70 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.60494996 |
| 71 | postsynaptic membrane organization (GO:0001941) | 3.59622864 |
| 72 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.59609344 |
| 73 | regulation of protein kinase A signaling (GO:0010738) | 3.59526912 |
| 74 | protein localization to synapse (GO:0035418) | 3.55706583 |
| 75 | glycine transport (GO:0015816) | 3.55631423 |
| 76 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.55258031 |
| 77 | regulation of synaptic vesicle transport (GO:1902803) | 3.53628395 |
| 78 | positive regulation of membrane potential (GO:0045838) | 3.52731176 |
| 79 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.52299341 |
| 80 | cAMP metabolic process (GO:0046058) | 3.51159485 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.47258277 |
| 82 | cellular sodium ion homeostasis (GO:0006883) | 3.46858228 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.45329345 |
| 84 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.44673042 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 3.42482833 |
| 86 | synaptic transmission, glutamatergic (GO:0035249) | 3.41219439 |
| 87 | positive regulation of dendritic spine development (GO:0060999) | 3.41217776 |
| 88 | layer formation in cerebral cortex (GO:0021819) | 3.40800801 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 3.40274938 |
| 90 | visual learning (GO:0008542) | 3.37866945 |
| 91 | regulation of neurotransmitter levels (GO:0001505) | 3.37283556 |
| 92 | regulation of postsynaptic membrane potential (GO:0060078) | 3.36399255 |
| 93 | neuromuscular process controlling posture (GO:0050884) | 3.36109740 |
| 94 | mechanosensory behavior (GO:0007638) | 3.35400232 |
| 95 | regulation of neurotransmitter secretion (GO:0046928) | 3.35167382 |
| 96 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34191234 |
| 97 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.34059026 |
| 98 | axon ensheathment in central nervous system (GO:0032291) | 3.33965226 |
| 99 | central nervous system myelination (GO:0022010) | 3.33965226 |
| 100 | membrane hyperpolarization (GO:0060081) | 3.31456751 |
| 101 | regulation of ARF protein signal transduction (GO:0032012) | 3.28180938 |
| 102 | glutamate secretion (GO:0014047) | 3.26942024 |
| 103 | neuronal action potential (GO:0019228) | 3.22914218 |
| 104 | female mating behavior (GO:0060180) | 3.22755179 |
| 105 | neuromuscular process (GO:0050905) | 3.20818496 |
| 106 | behavioral defense response (GO:0002209) | 3.18625632 |
| 107 | behavioral fear response (GO:0001662) | 3.18625632 |
| 108 | cellular potassium ion homeostasis (GO:0030007) | 3.16958831 |
| 109 | visual behavior (GO:0007632) | 3.15764951 |
| 110 | regulation of cell communication by electrical coupling (GO:0010649) | 3.15614036 |
| 111 | glutamate receptor signaling pathway (GO:0007215) | 3.15342214 |
| 112 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.15314680 |
| 113 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.15217092 |
| 114 | cAMP biosynthetic process (GO:0006171) | 3.15076650 |
| 115 | regulation of dendritic spine development (GO:0060998) | 3.14441841 |
| 116 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.13995530 |
| 117 | response to amine (GO:0014075) | 3.13333131 |
| 118 | regulation of norepinephrine secretion (GO:0014061) | 3.13172855 |
| 119 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.11893395 |
| 120 | synaptic vesicle endocytosis (GO:0048488) | 3.09660775 |
| 121 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.07305371 |
| 122 | mating behavior (GO:0007617) | 3.06858710 |
| 123 | response to histamine (GO:0034776) | 3.06503653 |
| 124 | regulation of Rap GTPase activity (GO:0032317) | 3.05938525 |
| 125 | regulation of neurotransmitter transport (GO:0051588) | 3.05683159 |
| 126 | neurotransmitter uptake (GO:0001504) | 3.04704539 |
| 127 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.04279974 |
| 128 | * membrane depolarization during action potential (GO:0086010) | 3.02009143 |
| 129 | detection of calcium ion (GO:0005513) | 3.01761690 |
| 130 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.01613505 |
| 131 | drinking behavior (GO:0042756) | 3.01278188 |
| 132 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.01250822 |
| 133 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.97025305 |
| 134 | positive regulation of vesicle fusion (GO:0031340) | 2.95428267 |
| 135 | neuromuscular synaptic transmission (GO:0007274) | 2.93399121 |
| 136 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90691271 |
| 137 | neuron cell-cell adhesion (GO:0007158) | 2.87919047 |
| 138 | proline transport (GO:0015824) | 2.78413026 |
| 139 | * cell communication involved in cardiac conduction (GO:0086065) | 2.77476430 |
| 140 | * membrane depolarization (GO:0051899) | 2.77322364 |
| 141 | acidic amino acid transport (GO:0015800) | 2.77149877 |
| 142 | dendritic spine organization (GO:0097061) | 2.76293759 |
| 143 | positive regulation of dendrite development (GO:1900006) | 2.76096361 |
| 144 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.76095589 |
| 145 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.74666133 |
| 146 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.73573275 |
| 147 | regulation of synaptic transmission (GO:0050804) | 2.68885231 |
| 148 | * regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.66329348 |
| 149 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.65252507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.76677175 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 4.01143374 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06089372 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02062951 |
| 5 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.94710792 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.89695821 |
| 7 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84064938 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71116939 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71116939 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65582650 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59308438 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58806911 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56752364 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.55872831 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54783522 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.54451264 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.46708438 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31167451 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25118457 |
| 20 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21900162 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21270651 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.15077388 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10453135 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07935498 |
| 25 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06772867 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97612541 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79898100 |
| 28 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.67958902 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66335891 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65443208 |
| 31 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.56566525 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53162484 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49793853 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43669257 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43301068 |
| 36 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.42458767 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41009338 |
| 38 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.40250119 |
| 39 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.37237603 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36681067 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36068432 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33661902 |
| 43 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33104574 |
| 44 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26654911 |
| 45 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25796501 |
| 46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25264819 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25055534 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24808580 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23060169 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22338495 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22023819 |
| 52 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.21532080 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20582391 |
| 54 | AR_19668381_ChIP-Seq_PC3_Human | 1.20498679 |
| 55 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20225766 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19550907 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18669056 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17306339 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15325442 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12838312 |
| 61 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11363622 |
| 62 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11170535 |
| 63 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10273018 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10207430 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10048836 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09519452 |
| 67 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08333896 |
| 68 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07920959 |
| 69 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07426432 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06899227 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06791631 |
| 72 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.06745988 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06130015 |
| 74 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.05695769 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04435482 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03508253 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01602587 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00392385 |
| 79 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99625337 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97347876 |
| 81 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97267235 |
| 82 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96735106 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95620600 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95025723 |
| 85 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94937095 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93672319 |
| 87 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93532087 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93329168 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93021607 |
| 90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91861250 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91861250 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91250351 |
| 93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90741872 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90283064 |
| 95 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89823816 |
| 96 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88136954 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86416879 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86396192 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85345899 |
| 100 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85286281 |
| 101 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85041152 |
| 102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85012774 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84973673 |
| 104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84635963 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84530530 |
| 106 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84049477 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81758025 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81173665 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81167767 |
| 110 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80743471 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80263984 |
| 112 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.79724652 |
| 113 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.79611982 |
| 114 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.79031018 |
| 115 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78645802 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78017407 |
| 117 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.78010144 |
| 118 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77751915 |
| 119 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77743280 |
| 120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77302659 |
| 121 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77114059 |
| 122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76399110 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75399709 |
| 124 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.75271398 |
| 125 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.74028723 |
| 126 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.72302246 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.70343425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 8.91748121 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.96837891 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.84815380 |
| 4 | MP0003880_abnormal_central_pattern | 3.72294550 |
| 5 | MP0004270_analgesia | 3.55539811 |
| 6 | MP0009745_abnormal_behavioral_response | 3.47838787 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.19489791 |
| 8 | MP0009046_muscle_twitch | 2.90157319 |
| 9 | MP0002064_seizures | 2.81661184 |
| 10 | MP0001486_abnormal_startle_reflex | 2.63450467 |
| 11 | MP0001529_abnormal_vocalization | 2.60166746 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.56884370 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.52499020 |
| 14 | MP0002272_abnormal_nervous_system | 2.49306857 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.43287644 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.20553036 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.16547356 |
| 18 | MP0005646_abnormal_pituitary_gland | 1.96436893 |
| 19 | MP0008569_lethality_at_weaning | 1.92365615 |
| 20 | MP0005386_behavior/neurological_phenoty | 1.88745152 |
| 21 | MP0004924_abnormal_behavior | 1.88745152 |
| 22 | MP0001501_abnormal_sleep_pattern | 1.87840213 |
| 23 | MP0001970_abnormal_pain_threshold | 1.84363071 |
| 24 | MP0005409_darkened_coat_color | 1.84134554 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.82342938 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.82182657 |
| 27 | MP0004811_abnormal_neuron_physiology | 1.69616625 |
| 28 | MP0002736_abnormal_nociception_after | 1.68814319 |
| 29 | MP0000751_myopathy | 1.62509853 |
| 30 | MP0001984_abnormal_olfaction | 1.57972319 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.54220013 |
| 32 | MP0001346_abnormal_lacrimal_gland | 1.51184864 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.48567532 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.41852348 |
| 35 | MP0003075_altered_response_to | 1.39649218 |
| 36 | MP0001188_hyperpigmentation | 1.39512202 |
| 37 | MP0003329_amyloid_beta_deposits | 1.38911726 |
| 38 | MP0004858_abnormal_nervous_system | 1.37919706 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.36695638 |
| 40 | MP0003633_abnormal_nervous_system | 1.35770734 |
| 41 | MP0008874_decreased_physiological_sensi | 1.35309313 |
| 42 | MP0004145_abnormal_muscle_electrophysio | 1.35213181 |
| 43 | MP0003879_abnormal_hair_cell | 1.30027337 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.28424752 |
| 45 | MP0000955_abnormal_spinal_cord | 1.28319710 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.28135146 |
| 47 | MP0002184_abnormal_innervation | 1.27186467 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.23580610 |
| 49 | MP0003646_muscle_fatigue | 1.22980672 |
| 50 | MP0004885_abnormal_endolymph | 1.21784823 |
| 51 | MP0008872_abnormal_physiological_respon | 1.18968604 |
| 52 | MP0004085_abnormal_heartbeat | 1.16109635 |
| 53 | MP0001177_atelectasis | 1.13546427 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.08206845 |
| 55 | MP0005670_abnormal_white_adipose | 1.05821071 |
| 56 | MP0001905_abnormal_dopamine_level | 1.05405444 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.04613565 |
| 58 | MP0003631_nervous_system_phenotype | 1.01834230 |
| 59 | MP0000579_abnormal_nail_morphology | 1.00259500 |
| 60 | MP0005503_abnormal_tendon_morphology | 0.99817622 |
| 61 | MP0003690_abnormal_glial_cell | 0.99641230 |
| 62 | MP0000749_muscle_degeneration | 0.99543021 |
| 63 | MP0003283_abnormal_digestive_organ | 0.99528687 |
| 64 | MP0004036_abnormal_muscle_relaxation | 0.99161558 |
| 65 | MP0004142_abnormal_muscle_tone | 0.98547972 |
| 66 | MP0000920_abnormal_myelination | 0.97002326 |
| 67 | MP0005535_abnormal_body_temperature | 0.95105544 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.93912872 |
| 69 | MP0002638_abnormal_pupillary_reflex | 0.93022505 |
| 70 | MP0003137_abnormal_impulse_conducting | 0.92561241 |
| 71 | MP0004742_abnormal_vestibular_system | 0.92182598 |
| 72 | MP0000733_abnormal_muscle_development | 0.91899265 |
| 73 | MP0000747_muscle_weakness | 0.91748360 |
| 74 | MP0006276_abnormal_autonomic_nervous | 0.88295478 |
| 75 | MP0003123_paternal_imprinting | 0.86111190 |
| 76 | MP0002971_abnormal_brown_adipose | 0.85828476 |
| 77 | MP0002069_abnormal_eating/drinking_beha | 0.85786640 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.85077607 |
| 79 | MP0002249_abnormal_larynx_morphology | 0.84483814 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.84188797 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 0.84135500 |
| 82 | MP0000778_abnormal_nervous_system | 0.83823673 |
| 83 | MP0005620_abnormal_muscle_contractility | 0.83462506 |
| 84 | MP0005623_abnormal_meninges_morphology | 0.80977165 |
| 85 | MP0002108_abnormal_muscle_morphology | 0.80937785 |
| 86 | MP0003787_abnormal_imprinting | 0.80763633 |
| 87 | MP0002229_neurodegeneration | 0.79112451 |
| 88 | MP0002090_abnormal_vision | 0.79084982 |
| 89 | MP0004147_increased_porphyrin_level | 0.78613824 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.78028986 |
| 91 | MP0002152_abnormal_brain_morphology | 0.76230943 |
| 92 | MP0004130_abnormal_muscle_cell | 0.75647632 |
| 93 | MP0005388_respiratory_system_phenotype | 0.74987869 |
| 94 | MP0002133_abnormal_respiratory_system | 0.74987869 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.74618086 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.72129662 |
| 97 | MP0004043_abnormal_pH_regulation | 0.71200730 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.69939161 |
| 99 | MP0003634_abnormal_glial_cell | 0.69663379 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.69400718 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.69195607 |
| 102 | MP0004084_abnormal_cardiac_muscle | 0.69113192 |
| 103 | MP0006138_congestive_heart_failure | 0.68767184 |
| 104 | MP0004087_abnormal_muscle_fiber | 0.67693053 |
| 105 | MP0004233_abnormal_muscle_weight | 0.67164766 |
| 106 | MP0003122_maternal_imprinting | 0.65128521 |
| 107 | MP0005166_decreased_susceptibility_to | 0.65081919 |
| 108 | MP0010030_abnormal_orbit_morphology | 0.64333095 |
| 109 | MP0004510_myositis | 0.63521664 |
| 110 | MP0000759_abnormal_skeletal_muscle | 0.63415470 |
| 111 | MP0000604_amyloidosis | 0.61848128 |
| 112 | MP0005645_abnormal_hypothalamus_physiol | 0.61639835 |
| 113 | MP0002269_muscular_atrophy | 0.61020999 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.60367066 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.57690925 |
| 116 | MP0005499_abnormal_olfactory_system | 0.57690925 |
| 117 | MP0002106_abnormal_muscle_physiology | 0.53212706 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.52362931 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.50722857 |
| 120 | MP0003632_abnormal_nervous_system | 0.49678638 |
| 121 | MP0005369_muscle_phenotype | 0.48178345 |
| 122 | MP0001943_abnormal_respiration | 0.47403007 |
| 123 | MP0003956_abnormal_body_size | 0.45097682 |
| 124 | MP0001664_abnormal_digestion | 0.44762722 |
| 125 | MP0004484_altered_response_of | 0.43102690 |
| 126 | MP0000631_abnormal_neuroendocrine_gland | 0.42934448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.55254373 |
| 2 | Focal motor seizures (HP:0011153) | 7.21275104 |
| 3 | Focal seizures (HP:0007359) | 5.32235698 |
| 4 | Action tremor (HP:0002345) | 4.69381406 |
| 5 | Resting tremor (HP:0002322) | 4.59719775 |
| 6 | Torticollis (HP:0000473) | 4.23127574 |
| 7 | Annular pancreas (HP:0001734) | 4.22776713 |
| 8 | Ankle clonus (HP:0011448) | 4.12699071 |
| 9 | Obstructive sleep apnea (HP:0002870) | 4.03562615 |
| 10 | Poor eye contact (HP:0000817) | 3.89123565 |
| 11 | Visual hallucinations (HP:0002367) | 3.79747177 |
| 12 | Anxiety (HP:0000739) | 3.76898739 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.70207175 |
| 14 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.66553488 |
| 15 | Abnormal social behavior (HP:0012433) | 3.65890931 |
| 16 | Impaired social interactions (HP:0000735) | 3.65890931 |
| 17 | Diplopia (HP:0000651) | 3.64846951 |
| 18 | Abnormality of binocular vision (HP:0011514) | 3.64846951 |
| 19 | Focal dystonia (HP:0004373) | 3.58125308 |
| 20 | Craniofacial dystonia (HP:0012179) | 3.58045732 |
| 21 | Muscle fiber inclusion bodies (HP:0100299) | 3.57453046 |
| 22 | Depression (HP:0000716) | 3.56002844 |
| 23 | Febrile seizures (HP:0002373) | 3.44407127 |
| 24 | Nemaline bodies (HP:0003798) | 3.41868636 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.39402427 |
| 26 | Urinary urgency (HP:0000012) | 3.38784893 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.37869354 |
| 28 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.36082486 |
| 29 | Lower limb amyotrophy (HP:0007210) | 3.29997435 |
| 30 | Dysdiadochokinesis (HP:0002075) | 3.29796172 |
| 31 | Exercise-induced myalgia (HP:0003738) | 3.29167869 |
| 32 | Broad-based gait (HP:0002136) | 3.24238193 |
| 33 | Ankyloglossia (HP:0010296) | 3.23515699 |
| 34 | Dysmetric saccades (HP:0000641) | 3.20218924 |
| 35 | Muscle fiber splitting (HP:0003555) | 3.19803117 |
| 36 | Type 1 muscle fiber predominance (HP:0003803) | 3.19708985 |
| 37 | Absence seizures (HP:0002121) | 3.14450659 |
| 38 | Scanning speech (HP:0002168) | 3.09100003 |
| 39 | Atonic seizures (HP:0010819) | 3.05988197 |
| 40 | Gaze-evoked nystagmus (HP:0000640) | 3.04872221 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 3.00519943 |
| 42 | Distal lower limb amyotrophy (HP:0008944) | 2.99592894 |
| 43 | Supranuclear gaze palsy (HP:0000605) | 2.97257108 |
| 44 | Epileptic encephalopathy (HP:0200134) | 2.96650608 |
| 45 | Postural instability (HP:0002172) | 2.93573767 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.91370917 |
| 47 | Pointed chin (HP:0000307) | 2.89800635 |
| 48 | Tetraplegia (HP:0002445) | 2.88858011 |
| 49 | Dialeptic seizures (HP:0011146) | 2.88171360 |
| 50 | Dysmetria (HP:0001310) | 2.83812713 |
| 51 | Spastic gait (HP:0002064) | 2.80378936 |
| 52 | Stereotypic behavior (HP:0000733) | 2.79688132 |
| 53 | Truncal ataxia (HP:0002078) | 2.79136339 |
| 54 | Progressive cerebellar ataxia (HP:0002073) | 2.68300700 |
| 55 | Bundle branch block (HP:0011710) | 2.68057764 |
| 56 | Calcaneovalgus deformity (HP:0001848) | 2.66557817 |
| 57 | Papilledema (HP:0001085) | 2.65748248 |
| 58 | Polygenic inheritance (HP:0010982) | 2.64158089 |
| 59 | Intention tremor (HP:0002080) | 2.56037195 |
| 60 | Impaired vibratory sensation (HP:0002495) | 2.52186032 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.47694701 |
| 62 | Axonal loss (HP:0003447) | 2.45478592 |
| 63 | Clonus (HP:0002169) | 2.44961450 |
| 64 | Distal upper limb amyotrophy (HP:0007149) | 2.44655808 |
| 65 | Upper limb amyotrophy (HP:0009129) | 2.44655808 |
| 66 | Impaired smooth pursuit (HP:0007772) | 2.42697143 |
| 67 | EMG: myopathic abnormalities (HP:0003458) | 2.41588055 |
| 68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39490887 |
| 69 | Myopathic facies (HP:0002058) | 2.38594204 |
| 70 | Cerebral hypomyelination (HP:0006808) | 2.37362509 |
| 71 | Bradykinesia (HP:0002067) | 2.37154234 |
| 72 | Insidious onset (HP:0003587) | 2.36129718 |
| 73 | Termporal pattern (HP:0011008) | 2.36129718 |
| 74 | Abnormality of oral frenula (HP:0000190) | 2.33299985 |
| 75 | Megalencephaly (HP:0001355) | 2.31658138 |
| 76 | Exercise-induced muscle cramps (HP:0003710) | 2.31163498 |
| 77 | Sleep apnea (HP:0010535) | 2.30971261 |
| 78 | Lower limb muscle weakness (HP:0007340) | 2.29450756 |
| 79 | Onion bulb formation (HP:0003383) | 2.28913189 |
| 80 | Deformed tarsal bones (HP:0008119) | 2.28229195 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.28116677 |
| 82 | Hemiparesis (HP:0001269) | 2.25894070 |
| 83 | Difficulty running (HP:0009046) | 2.22263043 |
| 84 | Sudden death (HP:0001699) | 2.20785663 |
| 85 | Abnormality of the lower motor neuron (HP:0002366) | 2.20410960 |
| 86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18787636 |
| 87 | Incomplete penetrance (HP:0003829) | 2.18482926 |
| 88 | Frequent falls (HP:0002359) | 2.16876874 |
| 89 | Akinesia (HP:0002304) | 2.16236424 |
| 90 | Limb dystonia (HP:0002451) | 2.13156370 |
| 91 | Muscle stiffness (HP:0003552) | 2.12980396 |
| 92 | Fetal akinesia sequence (HP:0001989) | 2.12925256 |
| 93 | Hammertoe (HP:0001765) | 2.12763319 |
| 94 | Limb hypertonia (HP:0002509) | 2.10447776 |
| 95 | Foot dorsiflexor weakness (HP:0009027) | 2.05828398 |
| 96 | Pheochromocytoma (HP:0002666) | 2.05727991 |
| 97 | Hemiplegia (HP:0002301) | 2.04411866 |
| 98 | Lower limb asymmetry (HP:0100559) | 2.02494785 |
| 99 | Amblyopia (HP:0000646) | 2.02482999 |
| 100 | Myotonia (HP:0002486) | 2.02391904 |
| 101 | Bronchomalacia (HP:0002780) | 2.01482666 |
| 102 | Abnormality of saccadic eye movements (HP:0000570) | 2.01350733 |
| 103 | Status epilepticus (HP:0002133) | 2.00830429 |
| 104 | Progressive inability to walk (HP:0002505) | 1.99630623 |
| 105 | Bowel incontinence (HP:0002607) | 1.99582630 |
| 106 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.98942546 |
| 107 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.98658021 |
| 108 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.97383660 |
| 109 | * Abnormal EKG (HP:0003115) | 1.96656999 |
| 110 | Rigidity (HP:0002063) | 1.95221568 |
| 111 | Abnormality of pain sensation (HP:0010832) | 1.95072465 |
| 112 | Impaired pain sensation (HP:0007328) | 1.95072465 |
| 113 | * Heart block (HP:0012722) | 1.95043352 |
| 114 | Subaortic stenosis (HP:0001682) | 1.94782922 |
| 115 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.94782922 |
| 116 | Mutism (HP:0002300) | 1.93193749 |
| 117 | Abnormality of the foot musculature (HP:0001436) | 1.92744379 |
| 118 | Calf muscle hypertrophy (HP:0008981) | 1.92735527 |
| 119 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.92198905 |
| 120 | Round ear (HP:0100830) | 1.91619380 |
| 121 | Turricephaly (HP:0000262) | 1.89374421 |
| 122 | Abnormality of the periventricular white matter (HP:0002518) | 1.88612647 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 1.87688580 |
| 124 | Spinal canal stenosis (HP:0003416) | 1.85043780 |
| 125 | Dysphonia (HP:0001618) | 1.83708152 |
| 126 | Hyporeflexia of lower limbs (HP:0002600) | 1.82454382 |
| 127 | Insomnia (HP:0100785) | 1.82453634 |
| 128 | Neuronal loss in central nervous system (HP:0002529) | 1.82324263 |
| 129 | Slow progression (HP:0003677) | 1.81830346 |
| 130 | * Abnormal atrioventricular conduction (HP:0005150) | 1.81634273 |
| 131 | Cerebral aneurysm (HP:0004944) | 1.81156341 |
| 132 | Truncus arteriosus (HP:0001660) | 1.81049111 |
| 133 | Abnormal large intestine physiology (HP:0012700) | 1.81023763 |
| 134 | Apathy (HP:0000741) | 1.80394229 |
| 135 | Epileptiform EEG discharges (HP:0011182) | 1.79585163 |
| 136 | Rapidly progressive (HP:0003678) | 1.79156521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.37989518 |
| 2 | NTRK3 | 4.06341363 |
| 3 | MAP3K9 | 3.24825994 |
| 4 | KSR2 | 2.86171200 |
| 5 | PRKD3 | 2.69707555 |
| 6 | DAPK2 | 2.61819243 |
| 7 | RIPK4 | 2.56323003 |
| 8 | CAMKK1 | 2.47714171 |
| 9 | MINK1 | 2.28034746 |
| 10 | NTRK1 | 2.27118981 |
| 11 | MAP3K4 | 1.83725495 |
| 12 | FES | 1.83209572 |
| 13 | TAOK1 | 1.81387001 |
| 14 | PAK6 | 1.68627332 |
| 15 | CAMKK2 | 1.62818626 |
| 16 | MAP3K2 | 1.61146467 |
| 17 | NTRK2 | 1.56878697 |
| 18 | PINK1 | 1.53940494 |
| 19 | MAP3K13 | 1.52659120 |
| 20 | CDK5 | 1.52229834 |
| 21 | ARAF | 1.49763811 |
| 22 | KSR1 | 1.45226879 |
| 23 | PHKG2 | 1.40703237 |
| 24 | PHKG1 | 1.40703237 |
| 25 | LMTK2 | 1.38461111 |
| 26 | MAPK12 | 1.34457732 |
| 27 | TYRO3 | 1.30834882 |
| 28 | NEK1 | 1.30371017 |
| 29 | MAP2K4 | 1.30020707 |
| 30 | MARK1 | 1.29296244 |
| 31 | DAPK1 | 1.26660880 |
| 32 | STK38 | 1.24034692 |
| 33 | SIK2 | 1.18959120 |
| 34 | TNIK | 1.18032620 |
| 35 | MAP2K7 | 1.17673946 |
| 36 | SGK223 | 1.15980808 |
| 37 | SGK494 | 1.15980808 |
| 38 | CASK | 1.11569247 |
| 39 | PRKCH | 1.10000994 |
| 40 | SGK2 | 1.06492554 |
| 41 | SGK3 | 1.05466072 |
| 42 | TRIB3 | 1.03333059 |
| 43 | WNK1 | 1.03301787 |
| 44 | RIPK1 | 1.02293860 |
| 45 | RAF1 | 1.01925945 |
| 46 | DYRK1A | 1.00128346 |
| 47 | MOS | 0.98209752 |
| 48 | PRPF4B | 0.97333089 |
| 49 | PLK2 | 0.95908573 |
| 50 | RET | 0.95322594 |
| 51 | PDPK1 | 0.88639650 |
| 52 | TNK2 | 0.86530599 |
| 53 | EEF2K | 0.85755156 |
| 54 | BMPR2 | 0.84815916 |
| 55 | MAP3K1 | 0.84520915 |
| 56 | UHMK1 | 0.83550220 |
| 57 | STK11 | 0.82464339 |
| 58 | PRKCG | 0.82311070 |
| 59 | MARK2 | 0.81047579 |
| 60 | SGK1 | 0.80894096 |
| 61 | PDK1 | 0.80630934 |
| 62 | MAPK13 | 0.75594604 |
| 63 | ROCK2 | 0.75242504 |
| 64 | PKN1 | 0.73965352 |
| 65 | ALK | 0.73936178 |
| 66 | SCYL2 | 0.71352663 |
| 67 | MAP2K1 | 0.70481306 |
| 68 | CDK15 | 0.70309706 |
| 69 | DMPK | 0.70275373 |
| 70 | CAMK1 | 0.69818643 |
| 71 | CDK18 | 0.69538374 |
| 72 | CDK14 | 0.68242149 |
| 73 | TRPM7 | 0.64600412 |
| 74 | CAMK2A | 0.64252781 |
| 75 | OBSCN | 0.61243784 |
| 76 | CDK11A | 0.59903226 |
| 77 | CAMK2B | 0.58862187 |
| 78 | PTK2B | 0.58583954 |
| 79 | RPS6KA3 | 0.58261245 |
| 80 | DDR2 | 0.57740070 |
| 81 | NEK6 | 0.56475557 |
| 82 | BRSK1 | 0.55332929 |
| 83 | MAP3K12 | 0.54697193 |
| 84 | MAP3K7 | 0.53222688 |
| 85 | MAPK7 | 0.51838238 |
| 86 | ROCK1 | 0.51677798 |
| 87 | TESK1 | 0.51239448 |
| 88 | MAPK10 | 0.49683036 |
| 89 | GRK5 | 0.49673667 |
| 90 | FYN | 0.48740126 |
| 91 | CAMK2G | 0.48711515 |
| 92 | PRKD2 | 0.47736068 |
| 93 | PRKCZ | 0.46781888 |
| 94 | CAMK4 | 0.46437401 |
| 95 | DAPK3 | 0.43961212 |
| 96 | PRKG1 | 0.42784786 |
| 97 | LIMK1 | 0.42518734 |
| 98 | CDC42BPA | 0.41066630 |
| 99 | MUSK | 0.38880735 |
| 100 | BRAF | 0.38870517 |
| 101 | CAMK1G | 0.38074200 |
| 102 | PDGFRA | 0.37664239 |
| 103 | MAPK4 | 0.37466190 |
| 104 | PRKD1 | 0.37255528 |
| 105 | CAMK2D | 0.35898590 |
| 106 | RPS6KA2 | 0.35709828 |
| 107 | PRKACG | 0.33581121 |
| 108 | PRKCB | 0.33076618 |
| 109 | BMX | 0.32574241 |
| 110 | CAMK1D | 0.32125188 |
| 111 | MAP2K6 | 0.32058691 |
| 112 | PRKAA1 | 0.31961263 |
| 113 | CDK19 | 0.31815216 |
| 114 | PRKACA | 0.31166581 |
| 115 | FGFR2 | 0.30611775 |
| 116 | MAP3K11 | 0.30063664 |
| 117 | MAPKAPK5 | 0.30047819 |
| 118 | WNK4 | 0.29542816 |
| 119 | CSNK1A1 | 0.28897025 |
| 120 | TTN | 0.28725077 |
| 121 | PTK2 | 0.28247297 |
| 122 | MAPK8 | 0.28082084 |
| 123 | PAK3 | 0.26664000 |
| 124 | LATS2 | 0.26483770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.85309361 |
| 2 | Morphine addiction_Homo sapiens_hsa05032 | 2.70541691 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63147089 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.57169391 |
| 5 | Cocaine addiction_Homo sapiens_hsa05030 | 2.49245152 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48641315 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.47869938 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.46525071 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38733010 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.35726003 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.31653408 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.22291068 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.14277872 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.03307815 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.97989433 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.97179753 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91450702 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.90797809 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88170130 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.84508467 |
| 21 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77852042 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.74416333 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73169277 |
| 24 | Gap junction_Homo sapiens_hsa04540 | 1.55867826 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49953369 |
| 26 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.38434289 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.38011396 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.36924569 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35832106 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.32837846 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28904383 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25098191 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.18311028 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10247437 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09354473 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08930059 |
| 37 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.08002082 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07398894 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07338208 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05048005 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99692279 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97239954 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95601438 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91346931 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 0.89433974 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89014130 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87857321 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86604352 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85403171 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83046215 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81859067 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79371010 |
| 53 | Alcoholism_Homo sapiens_hsa05034 | 0.78844015 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77893775 |
| 55 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77424437 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76802430 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76702821 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76095750 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74999057 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72475768 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70531679 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70195265 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69629605 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.68483939 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68392583 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67741846 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67511263 |
| 68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67164209 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66336959 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 0.65898564 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.65813175 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64064121 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63332375 |
| 74 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60561130 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60478034 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60159583 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58552457 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56159522 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55496857 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55208981 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54442754 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53708328 |
| 83 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52816054 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.51837979 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.51389483 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50562735 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50299142 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50058249 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48423091 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.47689278 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47257807 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47163098 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46865377 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45415407 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42633737 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40865316 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.40488206 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38541012 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.38398576 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38271809 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37478137 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35947134 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.35779269 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35080962 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35043899 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33919728 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33132505 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32899870 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32230472 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.31971268 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31922988 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31881447 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29908678 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29838492 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.29438987 |
| 116 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.27777301 |

